Why the study?
Does perioperative dual antiplatelet therapy prevent ischemic events in patients undergoing carotid artery stenting?
Does perioperative dual antiplatelet therapy prevent ischemic events in patients undergoing carotid artery stenting?
Dual antiplatelet therapy is the standard perioperative management strategy to prevent ischemic complications during carotid artery stenting.
Supports DAPT as perioperative standard in carotid stenting; leaves open questions on optimal duration and alternatives.
Carotid artery stenting (CAS) is less invasive and has a lower incidence of systemic complications such as myocardial infarction compared with carotid endarterectomy. However, CAS is known to have a high incidence of ischemic complications due to distal thromboembolism. Progress has been made in the development of various distal protection devices and protection methods aimed at preventing thromboembolism. Similar to these methods, perioperative antiplatelet therapy is also able to play a very important role in the prevention of ischemic events. Dual antiplatelet therapy has become standard for perioperative management of CAS.
No takes yet. Share an insight, caveat, or question.
Enomoto et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: